Eczema drug dupilumab may rewire Itch-Sensing nerves
NCT ID NCT04823130
First seen Oct 31, 2025 · Last updated May 18, 2026 · Updated 20 times
Summary
This study looked at how dupilumab, a drug for moderate-to-severe eczema, changes nerve fibers in the skin and reduces itching. 54 adults with chronic itch took part. Researchers took skin samples to measure nerve density and branching before and after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number 2760001
Münster, 48149, Germany
-
Investigational Site Number 8400001
Miami, Florida, 33136, United States
-
Investigational Site Number 8400002
East Windsor, New Jersey, 08520, United States
Conditions
Explore the condition pages connected to this study.